D-1487-2019 Class II Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-1487-2019 was initiated by Pfizer Inc. on Jul 9, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Bags have the potential to leak. The recall status is terminated (terminated Oct 27, 2021). Affected quantity: 280340 bags.

Recall details

Product Type
Drugs
Report Date
Jul 24, 2019
Initiation Date
Jul 9, 2019
Termination Date
Oct 27, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
280340 bags

Product description

Milrinone Lactate Injection 200 mcg (0.2 mg)/mL* in 5% Dextrose Injection, 20 mg/100 mL, 100 mL bag, Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2776-23, Barcode (01)00304092776233.

Reason for recall

Lack of Assurance of Sterility: Bags have the potential to leak.

Distribution pattern

United States, PR, and Guam

Code information

Lot #s: 85-516-KL; 85-517-KL, Exp. 1JAN2020; 86-601-KL; 86-603-KL; 86-618-KL, Exp. 1FEB2020; 87-707-KL, Exp. 1MAR2020; 91-205-KL, Exp. 1JUL2020; 92-306-KL, Exp. 1AUG2020.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1487-2019
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-1487-2019. Report a data issue: hello@regdatalab.com.